Jonathan Weissman
Joined WhatDoTheyKnow in 2021
Send message to Jonathan Weissman
Sign in to change password, subscriptions and more (Jonathan Weissman only)
This person's Freedom of Information requests (approximately 11)
Host Cell Protein (HCP) Impurities in COVID-19 Vaccines
Follow up sent to Medicines and Healthcare Products Regulatory Agency by Jonathan Weissman on .
Long overdue.
Dear MHRA Customer Services,
The response to this freedom of information request (Ref: FOI 22/1128) has been delayed. Please update this request as s...
ALC-0159 purity and tetrahydrofuran contamination in Pfizer's BNT162b2
Response by Medicines and Healthcare Products Regulatory Agency to Jonathan Weissman on .
Refused.
Internal Review of FOI 22/462
Dear Mr Jonathan Weissman,
Please find attached the response to your Internal Review Request.
Kind Rega...
Contamination, exact ingredients and WFI GMP for Pfizer's product BNT162b2
Response by Medicines and Healthcare Products Regulatory Agency to Jonathan Weissman on .
Awaiting classification.
Internal Review of FOI 22/387
Dear Mr Jonathan Weissman
Thank you for your email.
Please find attached the reply to your Internal Rev...
RNA integrity of experimental modRNA COVID-19 drugs (Pfizer and Moderna)
Request to Medicines and Healthcare Products Regulatory Agency by Jonathan Weissman. Annotated by Matt Cooper on .
Refused.
Documents showing the RNA integrity of both processes were leaked in December 2020, which show the RNA integrity for BNT162b2.
Process 2 is inferior t...
Quality control of excipients in modRNA Pfizer and Moderna COVID-19 drugs
Response by Medicines and Healthcare Products Regulatory Agency to Jonathan Weissman on .
Refused.
Internal Review of FOI 22/476
Dear Mr Weissman,
Thank you for your email.
Please find attached the response to your Internal Review r...
Lipid-related impurity issues for BNT162b2
Response by Medicines and Healthcare Products Regulatory Agency to Jonathan Weissman on .
Refused.
Dear Jonathan Weissman,
Thank you for your email.
Please find attached the response to your internal review.
Kind Regards,
MHRA Customer Experienc...
Exact definitions of PF-07305885 and PF-07302048 in BNT162b2
Response by Medicines and Healthcare Products Regulatory Agency to Jonathan Weissman on .
Long overdue.
Thank you for your email. This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
W...
NaOH and HCl Excipients in Pfizer’s SmPC for Comirnaty
Response by Medicines and Healthcare Products Regulatory Agency to Jonathan Weissman on .
Long overdue.
Thank you for your email. This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
W...
Weight of water for injection in BNT162b2
Response by Medicines and Healthcare Products Regulatory Agency to Jonathan Weissman on .
Long overdue.
Thank you for your email. This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
W...
Important protocol deviations within 7 days after Dose 2 in BNT162b2 clinical trial
Response by Medicines and Healthcare Products Regulatory Agency to Jonathan Weissman on .
Long overdue.
Thank you for your email. This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
W...
Exact quantity of Water for Injection pre and post dilution in BNT162b2
Response by Medicines and Healthcare Products Regulatory Agency to Jonathan Weissman on .
Refused.
Dear Mr Weissman,
The full quantitative composition of each COVID-19 vaccine is exempt under
Section 41* and Section 43* of the FOI Act. The ful...
This person's annotations
None made.